ND6-28128-90913
1 vaccination
1 coded response
1 check-in
1 free-text entry
1 call case
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 111 / NY
- Registered
- 2021-07-20
- Relationship
- Self
- Race
- Asian
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-07-14
Dose 1 — Pfizer-BioNTech
-
2021-07-20
Registered in v-safe
-
2021-07-20
Survey response — days 1–6 daily, dose 1MedDRA: Delivery, Postpartum haemorrhage, Vaginal haemorrhage — Feeling: Fair · Get care from a doctor or other healthcare professionalFree text: Systemic reaction (other): Vaginal Bleeding postpartum · Healthcare visit (other): Back to labor and deliveryMedDRA releases: 2024-11 · check-in free text available
-
2021-07-20
Report sent to call center — days 1–6 daily, dose 1Get care from a doctor or other healthcare professional1 call case(s)
- 2021-07-26
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-07-14 | Pfizer-BioNTech | No |
Call center
1 call center case
1 unsuccessful
Free text
Release 9 — days 1–6 daily, dose 1
Systemic reaction (other): Vaginal Bleeding postpartum
Healthcare visit (other): Back to labor and delivery
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| HCVO | Delivery | · | · | ✓ |
| SRO | Postpartum haemorrhage | · | · | ✓ |
| SRO | Vaginal haemorrhage | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release